Bryan Irving

Corporate Officer/Principal at

3T Biosciences, Inc.

62 year

8 connections

Health Technology

Consumer Services

Finance

Profile

Bryan A Irving is currently the Chief Scientific Officer at 3T Biosciences, Inc. He previously worked as a Senior Advisor at Frazier Management LLC, Chief Scientific Officer & Executive VP at Five Prime Therapeutics, Inc., Vice President & Cancer Immunology at CytomX Therapeutics Holdings LLC, and Chief Scientific Officer at Amunix Pharmaceuticals, Inc. Dr. Irving received his undergraduate degree from the University of California, Berkeley and his doctorate from The University of California, San Francisco.

Bryan Irving active positions

Companies	Position	Start
3T Biosciences, Inc. 3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases	Corporate Officer/Principal	2023-09-30

All active positions of Bryan Irving

Former positions of Bryan Irving

Companies	Position	End
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer	Corporate Officer/Principal	2022-06-30
FIVE PRIME THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2019-05-29
CytomX Therapeutics Holdings LLC CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics	Private Equity Investor	2017-07-31
Frazier Management LLC Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions.	Consultant / Advisor	-

See the detail of Bryan Irving's experience

Training of Bryan Irving

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bryan Irving's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Frazier Management LLC Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions.	Finance
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases	Health Technology
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CytomX Therapeutics Holdings LLC CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology Engaged in the development of new generation targeted antibody therapeutics	Health Technology
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer	Health Technology
3T Biosciences, Inc. 3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases	Health Technology